Brief: AIM Vaccine Says Phase III Clinical Trial Of Serum-Free Rabies Vaccine Got Satisfactory Results
20/09/2023 15:07
Sept 20 (Reuters) - AIM Vaccine Co Ltd 6660.HK :
* PHASE III CLINICAL TRIAL OF SERUM-FREE RABIES VACCINE
ACHIEVED
SATISFACTORY PHASE RESULTS
Source text for Eikon: ID:nHKS7XXJMK
Further company coverage: 6660.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on AIM Vaccine
See all newsBrief: AIM Vaccine Co Submits Application For Human Diploid Cell Rabies Vaccine In China
Brief: AIM Vaccine Says Tibet Bohai To Subscribe 37.4 Million Shares At RMB1.07 Each
Brief: AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares
Brief: Aim Vaccine Says Serum-Free Rabies Vaccine Passes Inspection
Brief: AIM Vaccine Updates On 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine